This public procurement record has 5 releases in its history.

Award

10 Jul 2026 at 16:13

Award

18 Feb 2026 at 12:59

Award

04 Dec 2025 at 12:38

Tender

01 Aug 2025 at 10:51

Planning

22 May 2025 at 15:42

Summary of the contracting process

The procurement process overseen by NHS Blood and Transplant for the "Red Cell Genotyping" project has successfully progressed to the award and contract stages as of 10 July 2026. NHS Blood and Transplant, located in Bristol, spearheaded the competitive tender, focusing on the medical equipment industry. The procurement was aimed at red cell genotyping solutions crucial for ensuring safe blood transfusions. This initiative is not only significant within NHS Blood and Transplant but extends to other blood services across the UK. The framework agreement employed an open, competitive flexible procedure and is set to run from 1 February 2026 to 31 January 2033.

The awarded contract creates substantial growth opportunities for businesses involved in medical equipment supply, particularly those specialising in genotyping and related medical technologies. Small to medium-sized enterprises may find this contract particularly appealing due to the competitive nature of the framework and its framework agreement with reopening competition. Sussex Biological Limited, identified as a supplier, exemplifies the prospects available to businesses in the medical sector looking to expand their footprint through public service contracts. Such tenders typically require robust quality standards and the ability to handle both high-volume and urgent, smaller-scale demands, providing a diverse range of engagement possibilities for nimble and well-equipped suppliers.

How relevant is this notice?

Notice Title

Red Cell Genotyping (PA2023)

Notice Description

NHS Blood & Transplant (NHSBT) and Scottish National Blood Transfusion (SNBTS) Red Cell Immunohaematology (RCI) departments are awarding a supplier of red cell genotyping methods. The RCI laboratories in NHSBT and SNBTS provide a range of reference services to hospitals, focusing on ensuring safe and effective blood transfusions by diagnosing and managing complex issues related to red blood cells. For some patients, the red cell phenotype cannot be determined due to prior transfusion, treatment with therapeutic monoclonal antibodies, or autoimmune conditions. For these patients, the selection of safe compatible blood for transfusion relies on red cell genotyping, a molecular method of determining blood groups. Blood is often required urgently with increased risk to the patient if this is not met. RCI reference services in NHSBT are provided from Barnsley, Birmingham, Colindale, Filton (Bristol), Liverpool, Newcastle, and Tooting. RCI reference services in SNBTS are provided from Aberdeen, Dundee, Edinburgh, Glasgow and Inverness, although red cell genotyping is only performed on the Glasgow site. NHSBT and SNBTS have now completed a tender and shall award based on the following: * Extended red cell genotype (blood groups). * Weak and Partial Rh D. * Either closed or open system. * Processing batches, but also capable of processing smaller numbers with minimum wastage. * Less than 24-hour TAT, including DNA extraction to results. * Quality requirements (such as CE marked) The framework shall be utilised by NHS Blood and Transplant, Welsh Blood Service,, Scottish National Blood Transfusion Service and the Northern Ireland

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-051ec0
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/065319-2026
Current Stage
Award
All Stages
Planning, Tender, Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Competitive flexible procedure
Tender Suitability
SME, VCSE
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33000000 - Medical equipments, pharmaceuticals and personal care products

33100000 - Medical equipments

Notice Value(s)

Tender Value
£2,000,000 £1M-£10M
Lots Value
£2,000,000 £1M-£10M
Awards Value
£1,586,933 £1M-£10M
Contracts Value
£2,898,933 £1M-£10M

Notice Dates

Publication Date
10 Jul 20261 months ago
Submission Deadline
29 Aug 2025Expired
Future Notice Date
8 Oct 2025Expired
Award Date
3 Dec 20258 months ago
Contract Period
1 Feb 2026 - 31 Jan 2033 Over 5 years
Recurrence
2026-02-27

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS Blood and Transplant
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
BRISTOL
Postcode
BS34 7QH
Postcode Area
Bristol
Country
England

Major Region (ITL 1)
TLK South West (England)
Basic Region (ITL 2)
TLK5 West of England
Small Region (ITL 3)
TLK52 Bath & North East Somerset and South Gloucestershire
Delivery Location
Not specified

Local Authority
South Gloucestershire
Electoral Ward
Filton
Westminster Constituency
Filton and Bradley Stoke

Supplier Information

Number of Suppliers
1
Supplier Name

Sussex Biological Limited

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...